BioRestorative Therapies, a life sciences company focused on adult stem cell-based therapies for various medical applications, announced that it has named Gregory Lutz, MD, chief medical advisor for spine medicine.
Dr. Lutz is an associate professor of clinical rehabilitation medicine at Weill Medical College of Cornell University in New York and an attending physician at the Hospital for Special Surgery, also in New York.
Dr. Lutz will be responsible for advancing the company's brtxDISC program, including preparing the company's Investigational New Drug/Investigational Device Exemption application with the U.S. Food and Drug Administration.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws